Abstract
Glioblastoma multiforme (GBM) is a lethal tumor and radiation therapy remains one of the main treatments. New strategies are needed to overcome the resistance to treatment; one of which is based on the inhibition of transcription factors (TFs) activity. There is evidence that E2F family members may be promising targets for anti-cancer therapy due to their functions related to proliferatio…